Skip to content
2000
Volume 5, Issue 4
  • ISSN: 1872-3128
  • E-ISSN: 1874-0758

Abstract

The effect of oxidative stress (OS) on the pharmacokinetics of clomipramine (CPM), particularly addressing the change of CPM distribution to plasma components, was studied in ferric-nitrilotriacetate-induced oxidative-stress model rats (OS rats). First, CPM pharmacokinetic studies in OS rats were performed using CPM continuous infusion (17.5 μg/min/kg). Plasma concentration of CPM at a steady state in OS rats (0.20 ± 0.02 μg/mL) was significantly lower than that in control rats (0.30 ± 0.02 μg/mL). However, no difference was found in the amounts of CPM in the brains of control rats (1.67 ± 0.13 μg/g) and OS rats (1.63 ± 0.09 μg/g). Both of plasma unbound fraction and distribution to erythrocytes in OS rats were significantly higher than those of control rats. These results suggest that the lower CPM concentration in plasma in OS condition does not induce an inferior pharmacological effect.

Loading

Article metrics loading...

/content/journals/dml/10.2174/187231211798472548
2011-12-01
2025-10-02
Loading full text...

Full text loading...

/content/journals/dml/10.2174/187231211798472548
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test